Chen, V.J.; Hernandez-Meza, G.; Agrawal, P.; Zhang, C.A.; Xie, L.; Gong, C.L.; Hoerner, C.R.; Srinivas, S.; Oermann, E.K.; Fan, A.C.
Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma. Cancers 2019, 11, 1000.
https://doi.org/10.3390/cancers11071000
AMA Style
Chen VJ, Hernandez-Meza G, Agrawal P, Zhang CA, Xie L, Gong CL, Hoerner CR, Srinivas S, Oermann EK, Fan AC.
Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma. Cancers. 2019; 11(7):1000.
https://doi.org/10.3390/cancers11071000
Chicago/Turabian Style
Chen, Viola J., Gabriela Hernandez-Meza, Prashasti Agrawal, Chiyuan A. Zhang, Lijia Xie, Cynthia L. Gong, Christian R. Hoerner, Sandy Srinivas, Eric K. Oermann, and Alice C. Fan.
2019. "Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma" Cancers 11, no. 7: 1000.
https://doi.org/10.3390/cancers11071000
APA Style
Chen, V. J., Hernandez-Meza, G., Agrawal, P., Zhang, C. A., Xie, L., Gong, C. L., Hoerner, C. R., Srinivas, S., Oermann, E. K., & Fan, A. C.
(2019). Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma. Cancers, 11(7), 1000.
https://doi.org/10.3390/cancers11071000